Report overview
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
This report contains market size and forecasts of Pulmonary Drug Delivery Devices/Systems in global, including the following market information:
Global Pulmonary Drug Delivery Devices/Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pulmonary Drug Delivery Devices/Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pulmonary Drug Delivery Devices/Systems companies in 2021 (%)
The global Pulmonary Drug Delivery Devices/Systems market was valued at 2877.4 million in 2021 and is projected to reach US$ 3791.5 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metered Dose Inhalers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Drug Delivery Devices/Systems include Hovione, 3M Health Care, Bespak, BeyonDevices, GlaxoSmithKline, H&T Presspart, PARI Respiratory Equipment, Philips Respironics and SHL. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pulmonary Drug Delivery Devices/Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Devices/Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, by Type, 2021 (%)
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Global Pulmonary Drug Delivery Devices/Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Homecare
Global Pulmonary Drug Delivery Devices/Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Devices/Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Devices/Systems revenues share in global market, 2021 (%)
Key companies Pulmonary Drug Delivery Devices/Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pulmonary Drug Delivery Devices/Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
